REGENERON PHARMACEUTICALS, INC. Annual Return On Assets in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2011 to 2023.
  • Regeneron Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was 13.2 %, a 0.99% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Return On Assets for 2023 was 12.6 %, a 20.1% decline from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Return On Assets for 2022 was 15.7 %, a 57% decline from 2021.
  • Regeneron Pharmaceuticals, Inc. annual Return On Assets for 2021 was 36.6 %, a 65% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 12.6 -3.16 -20.1% Jan 1, 2023 Dec 31, 2023
2022 15.7 -20.8 -57% Jan 1, 2022 Dec 31, 2022
2021 36.6 +14.4 +65% Jan 1, 2021 Dec 31, 2021
2020 22.2 +6.7 +43.4% Jan 1, 2020 Dec 31, 2020
2019 15.5 -7.9 -33.8% Jan 1, 2019 Dec 31, 2019
2018 23.4 +9 +62.7% Jan 1, 2018 Dec 31, 2018
2017 14.4 +0.53 +3.83% Jan 1, 2017 Dec 31, 2017
2016 13.8 +0.79 +6.06% Jan 1, 2016 Dec 31, 2016
2015 13 +3.57 +37.7% Jan 1, 2015 Dec 31, 2015
2014 9.46 -6.69 -41.4% Jan 1, 2014 Dec 31, 2014
2013 16.2 -29.7 -64.7% Jan 1, 2013 Dec 31, 2013
2012 45.8 +65.9 Jan 1, 2012 Dec 31, 2012
2011 -20 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.